Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria

Infection and Immunity

Volumn 72, Issue 9, 2004, Pages 5027-5030

  Staalsoe, Trine ^a   Shulman, Caroline E ^b,c   Dorman, Edgar K ^b,c   Kawuondo, Ken ^c   Marsh, Kevin ^c   Hviid, Lars ^a  

^a Rigshospitalet   (Denmark)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIMALARIAL AGENT; CHONDROITIN 4 SULFATE; FANSIDAR; IMMUNOGLOBULIN G; PLACEBO; UNCLASSIFIED DRUG; VARIANT SURFACE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG INTERMITTENT THERAPY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MATERNAL MORBIDITY; NONHUMAN; PLASMODIUM FALCIPARUM; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIMALARIALS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY TRIMESTER, THIRD; PYRIMETHAMINE; SULFADOXINE;

EID: 4544222257     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.9.5027-5030.2004     Document Type: Article

References (25)

1. Altman, D. G., D. Machin, T. N. Bryant, and M. J. Gardner. 2000. Statistics with confidence. British Medical Journal, London, United Kingdom.
2. Beeson, J. G., G. V. Brown, M. E. Molyneux, C. Mhango, F. Dzinjalamala, and S. J. Rogerson. 1999. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J. Infect. Dis. 180:464-472.
3. Brabin, B. J. 1983. An analysis of malaria in pregnancy in Africa. Bull. W. H. O. 61:1005-1016.
4. Bull, P. C., B. S. Lowe, M. Kortok, C. S. Molyneux, C. I. Newbold, and K. Marsh. 1998. Parasite antigens on the infected red cell are targets for naturally acquired immunity to malaria. Nat. Med. 4:358-360.
5. Cohen, S., I. A. McGregor, and S. Carrington. 1961. Gammaglobulin and acquired immunity to human malaria. Nature 192:733-737.
6. Duffy, P. E., and M. Fried. 2003. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun. 71:6620-6623.
7. Fried, M., and P. E. Duffy. 1996. Adherence of Plasmodium falciparum to chondroitin sulphate A in the human placenta. Science 272:1502-1504.
8. Fried, M., F. Nosten, A. Brockman, B. T. Brabin, and P. E. Duffy. 1998. Maternal antibodies block malaria. Nature 395:851-852.
9. Greenwood, A. M., C. Menendez, P. L. Alonso, S. Jaffar, P. Langerock, S. Lulat, J. Todd, B. M'Boge, N. Francis, and B. M. Greenwood. 1994. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans. R. Soc. Trop. Med Hyg. 88:681-682.
10. Guyatt, H. L., and R. W. Snow. 2001. Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans. R. Soc. Trop. Med. Hyg. 95:569-576.
11. Guyatt, H. L., and R. W. Snow. 2001. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am. J. Trop. Med. Hyg. 64:36-44.
12. Kyes, S., P. Horrocks, and C. Newbold. 2001. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol. 55:673-707.
13. Marsh, K., and R. J. Howard. 1986. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 231:150-153.
14. Maubert. B., N. Fievet, G. Tami, C. Boudin, and P. Deloron. 2000. Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta. Parasite Immunol. 22:191-199.
15. McGregor, I. A., S. P. Carrington, and S. Cohen. 1963. Treatment of East African P. falciparum malaria with West African human γ-globulin. Trans. R. Soc. Trop. Med. Hyg. 57:170-175.
16. Ofori, M. F., D. Dodoo, T. Staalsoe, J. A. L. Kurtzhals, K. Koram, T. G. Theander, B. D. Akanmori, and L. Hviid. 2002. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect. Immun. 70:2982-2988.
17. Ricke, C. H., T. Staalsoe, K. Koram, B. D. Akanmori, E. M. Riley, T. G. Theander, and L. Hviid. 2000. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparam-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulphate A. J. Immunol. 165:3309-3316.
18. Rogerson, S. J., S. C. Chaiyaroj, K. Ng, J. C. Reeder, and G. V. Brown. 1995. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J. Exp. Med. 182:15-20.
19. Rogerson, S. J., E. Chaluluka, M. Kanjala, P. Mkundika, C. Mhango, and M. E. Molyneux. 2000. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans. R. Soc. Trop. Med. Hyg. 94:549-553.
20. Salanti, A., T. Staalsoe, T. Lavstsen, A. T. R. Jensen, M. P. K. Sowa, D. E. Arnot, L. Hviid, and T. G. Theander. 2003. Selective upregulation of a single distinctly structured var gene in CSA-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol. Microbiol. 49:179-191.
21. Shulman, C. E., E. K. Dorman, F. Cutts, K. Kawuondo, J. N. Bulmer, N. Peshu, and K. Marsh. 1999. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353:632-636.
22. Staalsoe, T., H. A. Giha, D. Dodoo, T. G. Theander, and L. Hviid. 1999. Detection of antibodies to variant antigens on Plasmodium falciparum infected erythrocytes by flow cytometry. Cytometry 35:329-336.
23. Staalsoe, T., R. Megnekou, N. Fievet, C. H. Ricke, H. D. Zornig, R. Leke, D. W. Taylor, P. Deloron, and L. Hviid. 2001. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum infected erythrocytes that are associated with protection against placental parasitemia. J. Infect. Dis. 184:618-626.
24. Staalsoe, T., C. E. Shulman, J. N. Bulmer, K. Kawuondo, K. Marsh, and L. Hviid. 2004. Variant surface antigen-specific IgG and protection against the clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363:283-289.
25. Yamada, M., R. Steketee, C. Abramowsky, M. Kida, J. Wirima, D. Heymann, J. Rabbege, J. Breman, and M. Aikawa. 1989. Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study. Am. J. Trop. Med. Hyg. 41:161-168.